Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era

References

• Pharmaceutical CGMPs for the 21st Century – A Risk-Based Approach, Final Report: U.S Food and Drug Administration- Department of Health and Human Services; 2004. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM176374.pdf [last accessed 19 November 2013]
   Google Scholar
• Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance: U.S. Food and Drug Administration – Center for Drug Evaluation and Research, Center for Veterinary Medicine and Office of Regulatory Affairs; 2004. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070305.pdf [last accessed 19 November 2013]
   Google Scholar
• Q8(R2) Pharmaceutical Development: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH); 2009. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf [last accessed 19 November 2013]
   Google Scholar
• Scopus query: REF(“A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance”). Available from: http://www.scopus.com [last accessed 19 November 2013]
   Google Scholar
• Scopus query: REF(ich q8 pharmaceutical development). Available from: http://www.scopus.com [last accessed 19 November 2013]
   Google Scholar
• Didonato GC, Liebowitz SM. QbD, control strategy and the regulatory experience. Chim Oggi 2011;29:34–37
   Google Scholar
• Venkateshwaran TG, Simmons SP, Jagota N, et al. Global regulatory submissions for QbD: Wyeth's experience in the CMC pilot. Pharm Technol 2009;33:96–102
   Google Scholar
• Kettlewell R, Upfield J, Leak R, Harris A. Continuous verification – providing an alternative approach to process validation. Pharm Eng 2011;31:18–26
   Google Scholar
• Fitzgerald S. Process analytical technology: experiences with PAT-based submissions. Regul Rapp 2013;10:25–27
   Google Scholar
• Cook J, Cruañes MT, Gupta M, et al. Quality-by-Design: are we there yet? AAPS Pharm Sci Tech 2014;15:140–148
   PubMed Web of Science ®Google Scholar
• Kourti T, Davis B. The business benefits of quality by design (QbD). Pharm Eng 2012;32:52–62
   Google Scholar
• Johnston R, Lambert J, Stump E. An industry perspective on Quality by Design. BioProcess Int 2012;10:26–35
   Google Scholar
• Kowalski BR. Chemometrics: views and propositions. J Chem Inform Comput Sci 1975;15:201–203
   Google Scholar
• Matero S, Den Berg FV, Poutiainen S, et al. Towards better process understanding: chemometrics and multivariate measurements in manufacturing of solid dosage forms. J Pharm Sci 2013;102:1385–1403
   PubMed Web of Science ®Google Scholar
• Wold S, Sjöström M. Chemometrics, present and future success. Chemometr Intell Lab Syst 1998;44:3–14
   Web of Science ®Google Scholar
• Miletic I, Quinn S, Dudzic M, et al. An industrial perspective on implementing on-line applications of multivariate statistics. J Process Control 2004;14:821–836
   Web of Science ®Google Scholar
• Lopes VV, Menezes JC. Inferential sensor design in the presence of missing data: a case study. Chemometr Intell Lab Syst 2005;78:1–10
   Google Scholar
• Macho S, Larrechi MS. Near-infrared spectroscopy and multivariate calibration for the quantitative determination of certain properties in the petrochemical industry. TrAC Trends Anal Chem 2002;21:799–806
   Web of Science ®Google Scholar
• Kosanovich KA, Dahl KS, Piovoso MJ. Improved process understanding using multiway principal component analysis. Ind Eng Chem Res 1996;35:138–146
   Web of Science ®Google Scholar
• Kourti T, Lee J, Macgregor JF. Experiences with industrial applications of projection methods for multivariate statistical process control. Comput Chem Eng 1996;20:S745–S750
   Web of Science ®Google Scholar
• Forina M, Casale M, Oliveri P. Application of chemometrics to food chemistry. In: Brown SD, Tauler R, Walczak B, eds. Comprehensive chemometrics. Vol. 4. Oxford: Elsevier; 2009:75–128
   Google Scholar
• Yu H, MacGregor JF, Haarsma G, Bourg W. Digital imaging for online monitoring and control of industrial snack food processes. Ind Eng Chem Res 2003;42:3036–3044
   Web of Science ®Google Scholar
• Hibbert DB. Chemometric analysis of sensory data. In: Brown SD, Tauler R, Walczak B, eds. Comprehensive chemometrics. Vol. 4. Oxford: Elsevier; 2009:377–424
   Google Scholar
• Fernandez Pierna JA, Baeten V, Dardenne P, et al. Spectroscopic Imaging. In: Brown SD, Tauler R, Walczak B, eds. Comprehensive chemometrics. Vol. 4. Oxford: Elsevier; 2009:173–196
   Google Scholar
• Lourenço ND, Lopes JA, Almeida CF, et al. Bioreactor monitoring with spectroscopy and chemometrics: a review. Anal Bioanal Chem 2012;404:1211–1237
   PubMed Web of Science ®Google Scholar
• Fend R, Bessant C, Williams AJ, Woodman AC. Monitoring haemodialysis using electronic nose and chemometrics. Biosens Bioelectron 2004;19:1581–1590
   PubMedGoogle Scholar
• Bijnens L, Verbeeck R, Göhlmann HW, et al. Spectral map analysis of microarray data. In: Brown SD, Tauler R, Walczak B, eds. Comprehensive chemometrics. Vol. 4. Oxford: Elsevier; 2009:197–219
   Google Scholar
• Hopke PK. Environmental chemometrics. In: Brown SD, Tauler R, Walczak B, eds. Comprehensive chemometrics. Vol. 4. Oxford: Elsevier; 2009:55–74
   Google Scholar
• Castillo-Garit JA, Marrero-Ponce Y, Torrens F, García-Domenech R. Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices. J Pharm Sci 2008;97:1946–1976
   PubMedGoogle Scholar
• Brereton RG. Chemometrics: data analysis for the laboratory and chemical plant. Chichester: John Wiley & Sons Ltd; 2003
   Google Scholar
• Næs T, Isaksson T, Fearn T, Davies T. A user-friendly guide to multivariate calibration and classification. Chichester: NIR Publications; 2002
   Google Scholar
• Otto M. Chemometrics: statistics and computer application in analytical chemistry. Weinheim: Wiley-VCH; 1999
   Google Scholar
• Pomerantsev AL, Rodionova OY. Process analytical technology: a critical view of the chemometricians. J Chemometr 2012;26:299–310
   Web of Science ®Google Scholar
• Esbensen KH, Geladi P. Principal component analysis: concept, geometrical interpretation, mathematical background, algorithms, history, practice. In: Brown SD, Tauler R, Walczak B, eds. Comprehensive chemometrics. Vol. 2. Oxford: Elsevier; 2009:211–226
   Google Scholar
• Anderson E. The irises of the Gaspe Peninsula. Bull Amer Iris Soc 1935;59:2–5
   Google Scholar
• Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab Syst 2001;58:109–130
   Web of Science ®Google Scholar
• Geladi P, Kowalski BR. Partial least-squares regression: a tutorial. Anal Chim Acta 1986;185:1–17
   Web of Science ®Google Scholar
• Workman Jr J. The state of multivariate thinking for scientists in industry: 1980–2000. Chemometr Intell Lab Syst 2002;60:13–23
   Web of Science ®Google Scholar
• Chew W, Sharratt P. Trends in process analytical technology. Anal Methods 2010;2:1412–1438
   Web of Science ®Google Scholar
• Doherty SJ, Lange AJ. Avoiding pitfalls with chemometrics and PAT in the pharmaceutical and biotech industries. TrAC Trends Anal Chem 2006;25:1097–1102
   Web of Science ®Google Scholar
• Kjeldahl K, Bro R. Some common misunderstandings in chemometrics. J Chemometr 2010;24:558–564
   Web of Science ®Google Scholar
• Badertscher M, Pretsch E. Bad results from good data. TrAC Trends Anal Chem 2006;25:1131–1138
   Web of Science ®Google Scholar
• Armstrong NA. Pharmaceutical experimental design and interpretation. 2nd ed. Boca Raton: CRC Press; 2006
   Google Scholar
• Polizzi MA, García-Muñoz S. A framework for in-silico formulation design using multivariate latent variable regression methods. Int J Pharm 2011;418:235–242
   PubMedGoogle Scholar
• Mullarney MP, Leyva N. Modeling pharmaceutical powder-flow performance using particle-size distribution data. Pharm Technol 2009;33:126–134
   Google Scholar
• Ganguly J, Vogel G. Process Analytical Technology (PAT) and scalable automation for bioprocess control and monitoring: a case study. Pharm Eng 2006;26:8–20
   Google Scholar
• Challa S, Potumarthi R. Chemometrics-based process analytical technology (PAT) tools: applications and adaptation in pharmaceutical and biopharmaceutical industries. Appl Biochem Biotechnol 2013;169:66–76
   PubMed Web of Science ®Google Scholar
• Rajalahti T, Kvalheim OM. Multivariate data analysis in pharmaceutics: a tutorial review. Int J Pharm 2011;417:280–290
   PubMed Web of Science ®Google Scholar
• Sever NE, Warman M, Mackey S, et al. Chapter 35 – Process analytical technology in solid dosage development and manufacturing. In: Qiu Y, Chen Y, Zhang GGZ, Liu L, Porter WR, eds. Developing solid oral dosage forms. San Diego: Academic Press; 2009:827–841
   Google Scholar
• Luypaert J, Massart DL, Vander Heyden Y. Near-infrared spectroscopy applications in pharmaceutical analysis. Talanta 2007;72:865–883
   PubMed Web of Science ®Google Scholar
• Knop K, Kleinebudde P. PAT-tools for process control in pharmaceutical film coating applications. Int J Pharm 2013;457:527–536
   PubMed Web of Science ®Google Scholar
• De Beer T, Burggraeve A, Fonteyne M, et al. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes. Int J Pharm 2011;417:32–47
   PubMed Web of Science ®Google Scholar
• Saleemi AN, Rielly CD, Nagy ZK. Comparative investigation of supersaturation and automated direct nucleation control of crystal size distributions using ATR-UV/vis spectroscopy and FBRM. Cryst Growth Des 2012;12:1792–1807
   Google Scholar
• Jose GE, Folque F, Menezes JC, et al. Predicting mab product yields from cultivation media components, using near-infrared and 2D-fluorescence spectroscopies. Biotechnol Prog 2011;27:1339–1346
   PubMedGoogle Scholar
• Burggraeve A, Monteyne T, Vervaet C, et al. Process analytical tools for monitoring, understanding, and control of pharmaceutical fluidized bed granulation: a review. Eur J Pharm Biopharm 2013;83:2–15
   PubMed Web of Science ®Google Scholar
• Hennigan MC, Ryder AG. Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies. J Pharm Biomed Anal 2013;72:163–171
   PubMed Web of Science ®Google Scholar
• MacGregor JF, Jaeckle C, Kiparissides C, Koutoudi M. Process monitoring and diagnosis by multiblock PLS methods. AIChE J 1994;40:826–838
   Web of Science ®Google Scholar
• Kushner J IV. Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development. Pharm Dev Technol 2013;18:333–342
   PubMed Web of Science ®Google Scholar
• Shi Z, Zaborenko N, Reed DE. Latent variables-based process modeling of a continuous hydrogenation reaction in API synthesis of small molecules. J Pharm Innov 2013;8:1–10
   Google Scholar
• Huang J, Kaul G, Cai C, et al. Quality by design case study: an integrated multivariate approach to drug product and process development. Int J Pharm 2009;382:23–32
   PubMed Web of Science ®Google Scholar
• Muteki K, Swaminathan V, Sekulic SS, Reid GL. De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies. AAPS Pharm Sci Tech 2011;12:1324–1334
   PubMed Web of Science ®Google Scholar
• Tomba E, De Martin M, Facco P, et al. General procedure to aid the development of continuous pharmaceutical processes using multivariate statistical modeling-An industrial case study. Int J Pharm 2013;444:25–39
   PubMed Web of Science ®Google Scholar
• Cui Y, Song X, Chuang K, et al. Variable selection in multivariate modeling of drug product formula and manufacturing process. J Pharm Sci 2012;101:4597–4607
   PubMed Web of Science ®Google Scholar
• Sandler N, Wilson D. Prediction of granule packing and flow behavior based on particle size and shape analysis. J Pharm Sci 2010;99:958–968
   PubMed Web of Science ®Google Scholar
• Machin M, Liesum L, Peinado A. Implementation of modelling approaches in the QbD framework: examples from the Novartis experience. Eur Pharm Rev 2011;16:5–8
   Google Scholar
• Mercier SM, Diepenbroek B, Dalm MCF, et al. Multivariate data analysis as a PAT tool for early bioprocess development data. J Biotechnol 2013;167:262–270
   PubMedGoogle Scholar
• Huang J, Goolcharran C, Ghosh K. A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methods. Eur J Pharm Biopharm 2011;78:141–150
   PubMed Web of Science ®Google Scholar
• Lourenço V, Lochmann D, Reich G, et al. A quality by design study applied to an industrial pharmaceutical fluid bed granulation. Eur J Pharm Biopharm 2012;81:438–447
   PubMed Web of Science ®Google Scholar
• Yacoub F, Lautens J, Lucisano L, Banh W. Application of quality by design principles to legacy drug products. J Pharm Innov 2011;6:61–68
   Google Scholar